Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
fertility
Pharma
Merck KGaA expects Mavenclad generics to deal serious blow in US
After delivering solid growth in 2025, Germany’s Merck KGaA expects an onslaught of U.S. generics to its MS blockbuster Mavenclad this year.
Fraiser Kansteiner
Mar 5, 2026 11:30am
Workplaces labor to keep staff as fertility support falls short
Dec 3, 2025 7:10am
Ferring summons star power to celebrate World IVF Day
Jul 21, 2025 8:00am
Ferring launches online platform for male fertility education
Jun 20, 2024 11:50am
Cancer 'steals possibilities,' but Gilead is 'taking it back'
Nov 16, 2023 8:05am
Ferring halts shipments of fertility med Menopur
Oct 27, 2022 4:00pm
